Lung Microbiota and Metabolites Collectively Associate with Clinical Outcomes in Milder Stage COPD

By rosaguerrero • May 11, 2022

Madapoosi SS, Cruickshank-Quinn C, Opron K, Erb-Downward JR, Begley LA, Li G, Barjaktarevic I, Barr RG, Comellas AP, Couper D, Cooper CB, Freeman C, Han M, Kaner RJ, Labaki W, Martinez FJ, Ortega VE, Peters SP, Paine R, Woodruff P, Curtis JL, Huffnagle GB, Stringer KA, Bowler RP, Esther CR Jr, Reisdorph N, Huang YJ; SPIROMICS Research Group. Lung Microbiota and Metabolites Collectively Associate with Clinical Outcomes in Milder Stage COPD. Am J Respir Crit Care Med. 2022 May 10. doi: 10.1164/rccm.202110-2241OC. Epub ahead of print. PMID: 35536732.

Tags: bronchoscopy, lung function, metabolomics, microbiome, Publications, Pulmonary, Critical Care & Sleep Medicine

Related Posts

Association of Eicosanoids and Eicosanoid-Related Metabolites With Obesity and Cardiometabolic Traits

Chitsazan M, Parekh JK, Grundmann AL, Lau ES, Alotaibi M, Yu B, Rebholz CM, Selvin E, Allen NB, Allison MA, Jain M, Cheng S, Ho[...]

Associations of neighborhood deprivation with breast cancer tumor genomics, targeted treatment use, and survival

Podany EL, Foffano L, Gerratana L, Medford AJ, Heater NK, Nicolò E, Tapiavala S, Pontolillo L, Putur A, Jaber DA, Clifton K, Katakam N, Addison[...]

Epigenetic Clocks of Biological Aging and Cognitively Healthy Longevity: The Women’s Health Initiative Memory Study

LaCroix AZ, Zhang B, Nguyen S, Resnick SM, Ferrucci L, Horvath S, Lu AT, Espeland MA, Rapp SR, Beckman K, Nievergelt C, Maihofer AX, McEvoy[...]